HealthMore in Health→
Ovarian cancer study points to a metabolic weak spot in chemo resistance
Key Takeaways
- Researchers linked chemotherapy resistance in some ovarian cancers to a metabolic pathway involving alpha-ketoglutarate.
- The study identified TMLHE as an enzyme connected to tumor DNA repair capacity.
- The findings suggest an existing drug may help weaken resistance when paired with chemotherapy.
DE
DT Editorial Team··via medicalxpress.com